{
  "id": 1484,
  "text": "Seven RCTs1463-1469 not included in the systematic reviews/metaanalyses1379,1381,1402,1422,1423,1439,1440,1456,1457,1462 mentioned above was also identified.Kim et al.1463 designed a RCT for prophylactic para-aortic irradiation on the basis of hypoxia marker, CA9, to test whether concomitant cisplatin and extended-field irradiation can reduce para-aortic recurrences and increase disease-free survival rate in LACC.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Seven RCTs1463-1469 not included in the systematic reviews/metaanalyses1379,1381,1402,1422,1423,1439,1440,1456,1457,1462 mentioned above was also identified.Kim et al.1463 designed a RCT for prophylactic para-aortic irradiation on the basis of hypoxia marker, CA9, to test whether concomitant cisplatin and extended-field irradiation can reduce para-aortic recurrences and increase disease-free survi\n\n<question>: ",
  "ChatGPT_response_0": "根据提到的文献，Kim等人设计了一项RCT，以缺氧标志物CA9为基础，旨在测试伴随顺铂和扩展区域放疗是否能够降低腹主动脉复发率并提高晚期宫颈癌患者的无病生存率。然而，对于这种利用含氧酶CA9为基础设计的RCT是否能有效降低腹主动脉复发率并提高疾病无病生存率的问题，还需要更多的研究和数据支持来验证其有效性。在决定治疗方案时，应该综合考虑患者的具体情况和病情，与医疗专业人士进行充分沟通和讨论，以制定个性化的治疗方案。最终的治疗策略应该基于权威指南和临床实践经验，以期为患者提供最佳的治疗效果。",
  "query": "根据提到的文献和研究反映出的情况，你认为利用含氧酶CA9为基础设计的RCT是否能有效降低腹主动脉复发率并提高疾病无病生存率？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 根据提到的文献和研究反映出的情况，你认为利用含氧酶CA9为基础设计的RCT是否能有效降低腹主动脉复发率并提高疾病无病生存率？\n\n<reference text>: Seven RCTs1463-1469 not included in the systematic reviews/metaanalyses1379,1381,1402,1422,1423,1439,1440,1456,1457,1462 mentioned above was also identified.Kim et al.1463 designed a RCT for prophylactic para-aortic irradiation on the basis of hypoxia marker, CA9, to test whether concomitant cisplatin and extended-field irradiation can reduce para-aortic recurrences and increase disease-free survival rate in LACC.\n\n<reply>: ",
  "response": "根据提到的文献，Kim等人设计了一项RCT，以缺氧标志物CA9为基础，旨在测试伴随顺铂和扩展区域放疗是否能够降低腹主动脉复发率并提高晚期宫颈癌患者的无病生存率。然而，对于这种利用含氧酶CA9为基础设计的RCT是否能有效降低腹主动脉复发率并提高疾病无病生存率的问题，还需要更多的研究和数据支持来验证其有效性。在决定治疗方案时，应该综合考虑患者的具体情况和病情，与医疗专业人士进行充分沟通和讨论，以制定个性化的治疗方案。最终的治疗策略应该基于权威指南和临床实践经验，以期为患者提供最佳的治疗效果。"
}